Tarjetas Inteligentes :: Plataformas :: Tecnologías :: Lectores de Tarjetas :: Servicios Profesionales :: Integración :: e-Commerce :: Entrepreneurs +34 95 260 81 93 Contact 

Lectores de Tarjetas Inteligentes y Criptográficas. Firma Electrónica Avanzada, Tokens USBLectores de Tarjetas Plan Avanza Lector DNI electronicoLectores de Tarjetas Lector Mifare Tarjetas de Proximidad
usb token patentBajo Patente Industrial de Kalysis nº 2.186.534 :: O.E.P.M. :: may 9, 2001 - 10:53
:: Lectores de Tarjetas Inteligentes y Criptográficas. Firma Electrónica Avanzada, Tokens USB
Kalysis MEI®
Lector de Tarjetas Plan Avanza Patente Kalysis:: Lectores de Tarjetas Proximidad RFID Mifare
Kalysis Community Entrar o crear una cuenta Descargas Envíar Noticias Temas
Índice Usuarios Descargas Envíar Noticias Temas
tarjetas inteligentes Business Intelligence
 
Sep 09, 2010 - 01:33 AM
  
 Consorcio de Empresas Fabricantes de Lectores de Tarjetas y Tarjetas
Plan Avanza Lector DNI electrónico
    
 
Es seguro. Es Kalysis

Dispositivo lector de certificado electrónico en soporte tarjeta inteligente externo puerto USB DNI electrónico

Kalysis Lectores Tarjetas Inteligentes
· Editar Menu
· PRODUCTOS   SERVICIOS
· Lector de Tarjetas Token USB Firma Electrónica
· Lector Grabador Tarjetas Magnéticas
· Teclado Tarjetas Magnéticas e Inteligentes
· APLICACIONES
Tarjetas Inteligentes

· CLIENTES
· BUSINESS PARTNERS
· INVERSORES
· SALA DE PRENSA
· PATROCINIOS
· CONTACTO
· FAQs
· WEB SERVICES
· Propiedad Industrial
· Información Técnica
· Áreas de Aplicación
· ¿Por qué KALYSIS?
· Nuestros PRECIOS
· COTIZACIÓN EXPRESS
· PLAN AVANZA Dispositivo Lector de certificados
· FIRMA ELECTRÓNICA AVANZADA

Idioma
InglésEspañol
· Últimos 100 publicados
· Archivo de Artículos

Tendrá solo UNA
.Kalysis en sus favoritos

Sabía que...

... KALYSIS es portada del Nilson Report?


Issue 814, July 2004

... la patente 2.186.534 de Kalysis es la base de la aplicación del DNI Digital o de la firma electrónica en tarjeta inteligente?

... el "token USB" es un invento español patentado presentado publicamente en Bruselas?

...Los beneficios de pagos móviles crecerán drásticamente a USD20,000 millones en todo el mundo en 2005, de acuerdo con un nuevo informe estratégico de ARC Group. Esta cifra representa un crecimiento anual del 100%, y se deriva principalmente de nuevos tipos de transacción como prepago desde cajeros automáticos y otros innovadores ATMs.


Empleo en Kalysis GRUPO
Trabajar en Kalysis
¿Buscas hacer empresa?

Que no te pique la envidia. Ven a inventar a Kalysis


La concurrencia
Actualmente tenemos invitado(s) y Miembros

Eres un usuario anónimo. Puedes registrarte gratis haciendo clic aquí


Tarjetas Inteligentes Estadísticas
Tarjetas Inteligentes en Europa


Informe mundial del mercado de tarjetas inteligentes Gartner DataQuest

Firma Electrónica Avanzada

Legislación Firma Electrónica

Haga Contacto

Kalysis ServicesTodas las líneas han sido borradas. La nueva línea que emerge no conoce límites. Nuestros clientes ya están sacando ventaja de las posibilidades que ofrece un mercado altamente competitivo conducido por la tecnología. Para saber cómo podemos ayudar a su compañía a construir más fuertes y provechosas conexiones, por favor, contacte con Dennis Vyrich al +1 (206) 666-5259 o por e-mail

Kalysis Connections Regístrese ahora para tener conexión directa a Kalysis. Nuestra lista de noticias mensual y contenidos personalizados le mantendrán en la cresta de la ola del mercado de las transacciones electrónicas basadas en tarjetas inteligentes

Email:
Nota: Podrá dejar de estar suscrito cuando lo desee.
 Deseo ver un Ejemplo
 Últimos números:
Diciembre 2002
Enero 2003

Febrero 2003
Marzo 2003
Especial Abril-Mayo 2003

En Contacto
España Kalysis GRUPO - Plataforma Kalysis MEI
Acepta
Transferencia Bancaria
Pago a la Entrega
VisaMastercardAmerican Express
DiscovereCheck

EspañaKALYSIS Iberia, SL
Plaza de Uncibay 3
Primera Planta
29008 Málaga
ESPAÑA

+34 95 260 81 93
+34 686 500 726


Plano de Situación y Accesos

CENTRO DE ATENCIÓN AL CLIENTE Voz/Fax

+34 95 222 79 60

CENTRO DE INVESTIGACIÓN
BIC Euronova - Centro Europeo de Empresas e Innovación (CEEI)
Parque Tecnológico de Andalucía (PTA)
Málaga, ES 29590
ESPAÑA

+34 95 101 0608
+34 95 202 8872

INTERNACIONAL Voz/Fax

+1 20 6666 KALY
001 20 6666 5259

ANID - National Association of Researchers in Educational Methodology
Camino de las Aguas, 48
37003 Salamanca
España

KALYSIS, SA de CV
:: General Payment Services de México, SA de CV


Camino al Desierto de Los Leones Número 35
Colonia San Ángel Inn
01000 México, Distrito Federal


KALYSIS Central America
USA Office
9800 Southwest 62nd St
Miami, Florida 33173
USA

116 Northeast 3rd Avenue
Miami, Florida 33132
USA

KALYSIS Nicaragua, SA
Edificio Grupo Lacayo
Km 5½ Carretera Norte Managua
NICARAGUA


KALYSIS Argentina, S.R.L.
Avenida Santa Fe, 1944 Martínez CP. 1640
Buenos Aires
ARGENTINA


AVICARD Identificación
Avda. Gestido, M-26, S-17, Sangrila
Canelones
URUGUAY


KALYSIS Chile
Obispo Orrego, 42. Ñuñoa
Santiago de Chile
CHILE


KALYSIS Colombia SA
CRA 46 No 56-63
OFIC. 109
Edificio Argental
Medellín
COLOMBIA

INTERNACIONAL Voz/Fax

+1 20 6666 KALY
001 20 6666 5259


Red de Distribuidores Europeos de Kalysis
Distribuidores EMEA

Austria, Alemania, Suiza, Dinamarca, Suecia, Noruega, Finlandia, Polonia, República Checa, Eslovaquia, Hungría, Eslovenia, Croacia, Latvia, Estonia y Lituania

Relaciones con la prensa y medios de comunicación
Iraís Quintana:


Sindicar Artículos de Kalysis Community
Tarjetas Inteligentes


Noticias en la Red: A Look at Return on Invested Capital
Publicado por: Redacción
Inversores :: Investors &  VCs  Return on invested capital, or ROIC, is one of the most fundamental financial metrics. But despite its importance, it does not receive the same kind of press coverage as earnings per share (EPS), return on equity (ROE), and the price-to-earnings ratio (P/E). One reason is probably because you cannot obtain ROIC straight out of financial statements. Nevertheless, the concept is fundamental in measuring how much value a company creates.


So what exactly is ROIC? It is defined as the cash rate of return on capital that a company has invested. It is the true metric to measure the cash-on-cash yield of a firm and how effective it allocates capital:

ROIC = Net Operating Profits After Taxes / Invested Capital

Net Operating Profits After Taxes (NOPAT), the numerator, is perhaps the best metric to measure the cash generated by operating activities. It is better than net income because it excludes items such as investment income, goodwill amortization and interest expense, which are non-operating in nature.

For example, in its 2000 fiscal year, Cisco (Nasdaq: CSCO) had a net income of $2.7 billion, however more than $600 million (after-tax) was generated from investment income. Obviously, Cisco's net income is not very representative of the profitability of its operations. Once adjusted to reflect operating activities, Cisco's NOPAT amounted to $2.3 billion (goodwill was added back). NOPAT focuses on operations, which is why it is a better measure than net income and EPS. Fools do not invest in companies for their ability to generate investment income, but for the profitability of their core operations. The simplified formula to calculate NOPAT is as follows.

NOPAT equals:

Start with:
+ Reported Net Income

Add back:
+ Goodwill amortization
+ Non-recurring costs
+ Interest expense
+ Tax paid on investment and interest income (effective tax rate X investment income)

Subtract:
- Investment and interest income
- Tax shield from interest expenses (effective tax rate X interest expense)

As for invested capital, the denominator, it represents all the cash that debtholders and shareholders have invested in the company. Invested capital can be calculated by subtracting cash and equivalents and non-interest bearing current liabilities (NIBCLs) from total assets. Cash is being subtracted because it does not yet represent operating assets. As for NIBCLs, which include accounts payable, income tax payable, accrued liabilities, and others, they are subtracted from capital because they bear absolutely no cost (interest-free). Note that to calculate ROIC, we use the average invested capital for the period.

Invested Capital equals:

Start with:
+ Total assets

Subtract:
- Cash, S-T investments and L-T investments (excluding investments in strategic alliances)
- NIBCLs

Before I move on with further insights on ROIC, another concept must be introduced: the weighted average cost of capital (WACC). For without the WACC, ROIC is not very useful. The WACC represents the minimum rate of return (adjusted for risk) that a company must earn to create value for shareholders and debtholders. ROIC is measured against the WACC, which is what makes it such an important concept.

When the ROIC is greater than the WACC, it means that the firm creates value; otherwise it destroys value. In practice, a company with a ROIC of 25% and a cost of capital of 11%, has created 14 cents of pure economic value for every dollar invested. The difference between ROIC and WACC is called the ROIC-WACC spread (%), which is one of the most important valuation tools in securities analysis (For more information on the WACC, please read Dale Wettlaufer's Equity Isn't Free).

So what does all this mean for investors? To start with, Fools would be better off tracking ROIC-WACC spreads than EPS, net income or ROE. Studies have shown that stock prices are highly correlated with ROIC-WACC spreads. Value creation is the key, simply looking at EPS or net income does not indicate whether a company creates value or not. In some cases, even high sales growth can be harmful as new capital is being invested in value-destroying projects. EPS, net income, and growth does not tell how much capital was required to generate those numbers, which is a fundamental flaw in using these traditional metrics.

ROIC can also be used to understand why stocks trade at different multiples, whether we are talking about P/E, enterprise value/invested capital (EV/IC), or price-to-book value. The P/E ratio is not only a function of growth, but also ROIC. The market is perhaps the best example of such a relation. From 1995 to 1998, the S&P 500's P/E ratio increased from 15 to 25. Many analysts and market gurus were screaming loud and clear that the market was overvalued because it was trading at a premium multiple to its historical level. However, the reality is that while the P/E ratio expanded, there was also a significant rise in the market's ROIC as it rose from 15.5% to 25.5% (Source: CSFB, The Fat Tail That Wags the Dog). A high P/E ratio does not mean that a stock is overvalued, but simply that it is more valuable.

Perhaps one of the best growth and value creation stories I have seen so far is Network Appliance (Nasdaq: NTAP). From 1998 to 2000, Network Appliance grew its sales from $166 million to $579 million (88% annual growth). In the mean time, its ROIC increased from 44.6% to 57.3%, which is quite an achievement. In 2000, Network Appliance's cost of capital was around 18.2%, which means that its ROIC-WACC spread was an impressive 39.1%. Consequently, the stock has increased more than 2,400% since 1998.

Of course, we can't attribute the stock appreciation to a stellar ROIC alone. However, it was a major factor as we don't see many stocks with rising ROICs, especially at such a high level. In fact, economic theories predict the opposite: ROICs are expected to decline as competition eats up economic profits. Network Appliance's feat is even more impressive when we consider that there is a 500-pound gorilla named EMC (NYSE: EMC) in the storage industry. By the way, EMC's ROIC was 43.7% (annualized) for the first six months of 2000, which is considerably lower than Network Appliance's.

ROIC is a valuable tool to assess the quality of a company. Generally speaking, companies with higher ROICs are more valuable. While I do not pretend that it solves all questions related to valuation, it is nevertheless a strong improvement over EPS and net income. It is important for Fools to understand that it is not only the level of ROIC that matters, but also the trend. A declining ROIC may be an advanced indicator signaling that a company is having a hard time dealing with competition. On the other hand, an increasing ROIC may indicate that a company is distancing its competitors or that it is being more efficient at deploying capital.

In this article, I have introduced the concept of ROIC, which is at the foundation of the Economic Model. The methodology I have presented was simplified. For those who want to learn more about the mechanics of ROIC, I have provided Fools with my own 30-page report, The Mechanics of the Economic Model, as well as a spreadsheet using Oracle (Nasdaq: ORCL) as an example. Both documents can be downloaded here for free. My report is based on the readings below that I strongly recommend and on Bennett Stewart's Quest for Value.

Related Links:
  • Does Valuation Matter?, Paul Johnson, Paul Sylverstein
  • Thoughts On Valuation, Michael J. Mauboussin
  • Competitive Advantage Period "CAP": The Neglected Value Driver, Michael J. Mauboussin, Paul Johnson
  • A Look at ROIC, Dale Wettlaufer

    Nota: Longtime Fool Community member Andrew Chan steps up on the Hill today to discuss a highly important topic of valuation -- return on invested capital (ROIC). This builds upon his significant work on the subject for the McGill Investment Club, which he made available to other Fools through a free download.

  •  
    Relacionado
    · The Motley Fool
    · Forbes
    · Kalysis :: Líneas Smart Cards
    · Más acerca de Inversores :: Investors & VCs
    · Noticia por Redacción


    Nota más leída en Inversores :: Investors & VCs:
    EBITDA, una explicación del virtual concepto para la valoración real de empresas


    Token USB Inversores :: Investors &  VCs  USB Token Inversores :: Investors &  VCs

    "Noticias en la Red: A Look at Return on Invested Capital" | Entrar o crear una cuenta | 0 Comentarios
    Umbral
    Los comentarios son propiedad de quienes los publican. No somos responsables de su contenido.
    Buy female viagraBuy female viagra onlineBuy female viagra no prescriptionOrder female viagraPrice of female viagraDiscount female viagraCheap female viagraGeneric female viagrafemale viagra couponsfemale viagra pillsBuy premarinBuy premarin onlineBuy premarin no prescriptionOrder premarinPrice of premarinDiscount premarinCheap premarinGeneric premarinpremarin couponspremarin pillsBuy plavixBuy plavix onlineBuy plavix no prescriptionOrder plavixPrice of plavixDiscount plavixCheap plavixGeneric plavixplavix couponsplavix pillsBuy paxilBuy paxil onlineBuy paxil no prescriptionOrder paxilPrice of paxilDiscount paxilCheap paxilGeneric paxilpaxil couponspaxil pillsBuy zoviraxBuy zovirax onlineBuy zovirax no prescriptionOrder zoviraxPrice of zoviraxDiscount zoviraxCheap zoviraxGeneric zoviraxzovirax couponszovirax pillsBuy hydrochlorthiazideBuy hydrochlorthiazide onlineBuy hydrochlorthiazide no prescriptionOrder hydrochlorthiazidePrice of hydrochlorthiazideDiscount hydrochlorthiazideCheap hydrochlorthiazideGeneric hydrochlorthiazidehydrochlorthiazide couponshydrochlorthiazide pillsBuy neurontinBuy neurontin onlineBuy neurontin no prescriptionOrder neurontinPrice of neurontinDiscount neurontinCheap neurontinGeneric neurontinneurontin couponsneurontin pillsBuy deltasoneBuy deltasone onlineBuy deltasone no prescriptionOrder deltasonePrice of deltasoneDiscount deltasoneCheap deltasoneGeneric deltasonedeltasone couponsdeltasone pillsBuy clomidBuy clomid onlineBuy clomid no prescriptionOrder clomidPrice of clomidDiscount clomidCheap clomidGeneric clomidclomid couponsclomid pillsBuy propeciaBuy propecia onlineBuy propecia no prescriptionOrder propeciaPrice of propeciaDiscount propeciaCheap propeciaGeneric propeciapropecia couponspropecia pillsBuy doxycyclineBuy doxycycline onlineBuy doxycycline no prescriptionOrder doxycyclinePrice of doxycyclineDiscount doxycyclineCheap doxycyclineGeneric doxycyclinedoxycycline couponsdoxycycline pillsBuy flomaxBuy flomax onlineBuy flomax no prescriptionOrder flomaxPrice of flomaxDiscount flomaxCheap flomaxGeneric flomaxflomax couponsflomax pillsBuy inderalBuy inderal onlineBuy inderal no prescriptionOrder inderalPrice of inderalDiscount inderalCheap inderalGeneric inderalinderal couponsinderal pillsBuy diflucanBuy diflucan onlineBuy diflucan no prescriptionOrder diflucanPrice of diflucanDiscount diflucanCheap diflucanGeneric diflucandiflucan couponsdiflucan pillsBuy amoxilBuy amoxil onlineBuy amoxil no prescriptionOrder amoxilPrice of amoxilDiscount amoxilCheap amoxilGeneric amoxilamoxil couponsamoxil pillsBuy norvascBuy norvasc onlineBuy norvasc no prescriptionOrder norvascPrice of norvascDiscount norvascCheap norvascGeneric norvascnorvasc couponsnorvasc pillsBuy nizoralBuy nizoral onlineBuy nizoral no prescriptionOrder nizoralPrice of nizoralDiscount nizoralCheap nizoralGeneric nizoralnizoral couponsnizoral pillsBuy topamaxBuy topamax onlineBuy topamax no prescriptionOrder topamaxPrice of topamaxDiscount topamaxCheap topamaxGeneric topamaxtopamax couponstopamax pillsBuy celexaBuy celexa onlineBuy celexa no prescriptionOrder celexaPrice of celexaDiscount celexaCheap celexaGeneric celexacelexa couponscelexa pillsBuy tenorminBuy tenormin onlineBuy tenormin no prescriptionOrder tenorminPrice of tenorminDiscount tenorminCheap tenorminGeneric tenormintenormin couponstenormin pillsBuy cialisBuy cialis onlineBuy cialis no prescriptionOrder cialisPrice of cialisDiscount cialisCheap cialisGeneric cialiscialis couponscialis pillsBuy accutaneBuy accutane onlineBuy accutane no prescriptionOrder accutanePrice of accutaneDiscount accutaneCheap accutaneGeneric accutaneaccutane couponsaccutane pillsBuy nexiumBuy nexium onlineBuy nexium no prescriptionOrder nexiumPrice of nexiumDiscount nexiumCheap nexiumGeneric nexiumnexium couponsnexium pillsBuy flagylBuy flagyl onlineBuy flagyl no prescriptionOrder flagylPrice of flagylDiscount flagylCheap flagylGeneric flagylflagyl couponsflagyl pillsBuy levitraBuy levitra onlineBuy levitra no prescriptionOrder levitraPrice of levitraDiscount levitraCheap levitraGeneric levitraLevitra couponsLevitra pillsBuy keflexBuy keflex onlineBuy keflex no prescriptionOrder keflexPrice of keflexDiscount keflexCheap keflexGeneric keflexkeflex couponskeflex pillsBuy kamagraBuy kamagra onlineBuy kamagra no prescriptionOrder kamagraPrice of kamagraDiscount kamagraCheap kamagraGeneric kamagrakamagra couponskamagra pillsBuy cytotecBuy cytotec onlineBuy cytotec no prescriptionOrder cytotecPrice of cytotecDiscount cytotecCheap cytotecGeneric cytoteccytotec couponscytotec pillsBuy lasixBuy lasix onlineBuy lasix no prescriptionOrder lasixPrice of lasixDiscount lasixCheap lasixGeneric lasixlasix couponslasix pillsBuy synthroidBuy synthroid onlineBuy synthroid no prescriptionOrder synthroidPrice of synthroidDiscount synthroidCheap synthroidGeneric synthroidsynthroid couponssynthroid pillsBuy celebrexBuy celebrex onlineBuy celebrex no prescriptionOrder celebrexPrice of celebrexDiscount celebrexCheap celebrexGeneric celebrexcelebrex couponscelebrex pillsBuy viagraBuy viagra onlineBuy viagra no prescriptionOrder viagraPrice of viagraDiscount viagraCheap viagraGeneric viagraViagra pillsViagra couponsBuy lipitorBuy lipitor onlineBuy lipitor no prescriptionOrder lipitorPrice of lipitorDiscount lipitorCheap lipitorGeneric lipitorlipitor couponslipitor pillsBuy lexaproBuy lexapro onlineBuy lexapro no prescriptionOrder lexaproPrice of lexaproDiscount lexaproCheap lexaproGeneric lexaprolexapro couponslexapro pillsBuy zithromaxBuy zithromax onlineBuy zithromax no prescriptionOrder zithromaxPrice of zithromaxDiscount zithromaxCheap zithromaxGeneric zithromaxzithromax couponszithromax pillsBuy levaquinBuy levaquin onlineBuy levaquin no prescriptionOrder levaquinPrice of levaquinDiscount levaquinCheap levaquinGeneric levaquinlevaquin couponslevaquin pills


    Kalysis GRUPO © 2001-2008 Licensed Materials - Program Property of Kalysis. All Rights Reserved
    Licensed under one or more Spain Patents Nº 2,186,534 assigned to Kalysis Iberia, SL. MEI® is a trademark of Kalysis GRUPO
    All trademarks are the property of their respective companies. Technical data subject to change without notice

    NOTA LEGAL AMPLIADA

    Plaza de Uncibay, 3 - Primera Planta - 29008 Málaga - Andalucía - España - EU
    Inscrita en el Registro Mercantil nº 5 de Málaga. Tomo 3.322, Libro 2.234, Folio 45, Hoja MA-63694. Sociedad Limitada C.I.F. ES B92451996 Kalysis es un Operador Intracomunitario registrado en el V.I.E.S.
    © 2001-2008 Kalysis Iberia, SL